MDCX (Medicus Pharma) EBIT per Share: $-1.96 (TTM As of Mar. 2026)

What is Medicus Pharma EBIT per Share?

Medicus Pharma MDCX +4.07% 13 EBIT per Share is $-1.96 as of Mar. 2026. GuruFocus rates MDCX with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 811 Drug Manufacturers companies, Medicus Pharma ranks worse than 99.26% on this metric.

Medicus Pharma's EBIT per Share for the three months ended in Mar. 2026 was $-0.29. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.96.

During the past 3 years, the average EBIT per Share Growth Rate was -153.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Medicus Pharma's EBIT per Share or its related term are showing as below:

MDCX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -153.5 Med: -120 Max: -86.5
Current: -153.5

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Medicus Pharma was -86.50% per year. The lowest was -153.50% per year. And the median was -120.00% per year.

MDCX's 3-Year EBIT Growth Rate is ranked worse than
99.26% of 811 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs MDCX: -153.50

Medicus Pharma's EBIT for the three months ended in Mar. 2026 was $-8.67 Mil.

Medicus Pharma (NAS:MDCX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Medicus Pharma EBIT per Share Related Terms

Medicus Pharma EBIT per Share Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma EBIT per Share Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT per Share

-0.24

-0.15

-0.76

-1.16

-1.99

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT per Share	Get a 7-Day Free Trial													-0.42	-0.42	-0.83	-0.42	-0.29

13GF Score

Medicus Pharma Ltd MDCX

EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medicus Pharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Medicus Pharma's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

	EBIT per Share		(A: Dec. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-34.359	/	17.284
=	-1.99

Medicus Pharma's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

	EBIT per Share		(Q: Mar. 2026 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.668	/	29.541
=	-0.29

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.96

Frequently Asked Questions Learn more about EBIT per Share →

What does a EBIT per Share of $-1.96 mean?

Medicus Pharma (MDCX) has a EBIT per Share of $-1.96 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medicus Pharma and its competitors. According to the industry distribution chart, Medicus Pharma ranks #805 out of 811 companies in the Drug Manufacturers industry, placing it in the top 99.3%.

Is Medicus Pharma's EBIT per Share too high?

Medicus Pharma's current EBIT per Share is $-1.96. Based on the distribution chart, Medicus Pharma ranks #805 out of 811 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.

How does Medicus Pharma's EBIT per Share compare to NSRX and MIRA?

According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #805 out of 811 companies for EBIT per Share. This places Medicus Pharma in the lower half of its industry. The industry median EBIT per Share is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT per Share for a Drug Manufacturers company?

The median EBIT per Share among Drug Manufacturers companies is 7.80, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT per Share mean?

A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medicus Pharma and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Pharma's current EBIT per Share is $-1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medicus Pharma stock overvalued right now?

Medicus Pharma (MDCX) has a current EBIT per Share of $-1.96. The current EBIT per Share is $-1.96. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT per Share calculated?

EBIT per Share is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current EBIT per Share is $-1.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies NSRX MIRA SCLX LLY JNJ ABBV XSWX:ROP MRK XSWX:NOVN LSE:AZN OCSE:NOVO B AMGN GILD PFE BMY LSE:GSK XPAR:SAN TSE:4519 XTER:BAYN TSE:4578

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website https://www.medicuspharma.com

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

13GF Score

Get the complete analysis for MDCX

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42

Price

View MDCX Analysis

See EBIT per Share data for all stocks →